Skip to main navigation Skip to search Skip to main content

Direct oral anticoagulation interruption vs continuation in patients undergoing elective invasive coronary angiography or percutaneous coronary intervention: Design and rationale of the South Limburg Myocardial Infarction Study Group Trial 2 (SLIM-2)

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Direct oral anticoagulation interruption vs continuation in patients undergoing elective invasive coronary angiography or percutaneous coronary intervention: Design and rationale of the South Limburg Myocardial Infarction Study Group Trial 2 (SLIM-2)'. Together they form a unique fingerprint.
Sort by

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases